ARKG vs NUGT
ARK Genomic Revolution ETF vs Direxion Daily Gold Miners Bull 2X ETF
- • ARKG has the lower expense ratio at 0.75% vs 1.13% for NUGT.
- • NUGT pays a higher dividend yield (1.00%).
Side-by-side metrics
| Metric | ARKG | NUGT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 1.13% |
Dividend yield Trailing 12-month yield. | 0.00% | 1.00% |
AUM Assets under management — bigger funds are typically more liquid. | $2.21B | $762M |
YTD return | 66.55% | -15.61% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.11 | 0.75 |
P/E ratio | — | 14.98 |
Last price | $47.17 | $136.76 |
Inception | — | — |
Issuer | ARK | Direxion |
ARKG top holdings
| TWST | Twist Bioscience Corp | 8.75% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 8.73% |
| TEM | Tempus AI Inc Class A common stock | 8.36% |
| ABSI | Absci Corp | 5.56% |
| CRSP | CRISPR Therapeutics AG | 5.22% |
| GH | Guardant Health Inc | 4.88% |
| NTRA | Natera Inc | 4.71% |
| ILMN | Illumina Inc | 4.69% |
| LLY | Eli Lilly and Co | 3.92% |
| BEAM | Beam Therapeutics Inc | 3.69% |
NUGT top holdings
| GDX | VanEck Gold Miners ETF | 21.24% |
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $2.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 8.7% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About NUGT
NUGT (Direxion Daily Gold Miners Bull 2X ETF) is 2x daily performance of gold mining stocks. Managed by Direxion, the fund carries $762M in assets under management, an expense ratio of 1.13%, a dividend yield of 1.00%. Its largest holding is VanEck Gold Miners ETF (GDX), which represents 21.2% of the portfolio. Basic Materials is the fund's largest sector exposure at 100.0%.